FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 54 filers reported holding FORTE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $658 | -36.4% | 994 | 0.0% | 0.00% | – |
| Q2 2023 | $1,034 | -7.4% | 994 | -10.1% | 0.00% | – |
| Q1 2023 | $1,117 | -21.3% | 1,106 | -22.1% | 0.00% | – |
| Q4 2022 | $1,419 | +41.9% | 1,419 | +1.0% | 0.00% | – |
| Q3 2022 | $1,000 | -99.8% | 1,405 | -99.6% | 0.00% | – |
| Q2 2022 | $438,000 | -31.2% | 337,039 | -22.9% | 0.00% | – |
| Q1 2022 | $637,000 | -73.2% | 437,200 | -60.7% | 0.00% | – |
| Q4 2021 | $2,377,000 | +8389.3% | 1,111,353 | +11434.5% | 0.00% | – |
| Q3 2021 | $28,000 | -97.6% | 9,635 | -72.5% | 0.00% | – |
| Q2 2021 | $1,177,000 | +221.6% | 35,018 | +227.9% | 0.00% | – |
| Q1 2021 | $366,000 | -36.0% | 10,678 | -32.0% | 0.00% | – |
| Q4 2020 | $572,000 | +44.1% | 15,696 | +92.0% | 0.00% | – |
| Q3 2020 | $397,000 | +2105.6% | 8,177 | +567.5% | 0.00% | – |
| Q2 2020 | $18,000 | – | 1,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 66,390 | $2,232,000 | 1.54% |
| BVF INC/IL | 591,811 | $19,897,000 | 0.75% |
| Endurant Capital Management LP | 53,369 | $1,794,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,183,213 | $39,780,000 | 0.30% |
| Perceptive Advisors | 1,370,000 | $46,060,000 | 0.30% |
| ACT CAPITAL MANAGEMENT, LLC | 16,071 | $541,000 | 0.28% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 516,956 | $17,380,000 | 0.26% |
| Parkman Healthcare Partners LLC | 31,402 | $1,056,000 | 0.23% |
| Insight Advisors, LLC/ PA | 19,150 | $582,000 | 0.18% |
| MYDA Advisors LLC | 20,000 | $672,000 | 0.17% |